Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells
- DOI
- 10.1016/j.bmcl.2026.130779
- Published
- 2027-01
- Container
- Bioorganic & Medicinal Chemistry Letters
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmcl.2026.130779,
title = {Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells},
author = {Ying Sun and Hongzhu Chu and Yonggang Wei and Xinying Qian and Fei Ye and Hongchuan Zhao and Xinying Zhu and Jing Zhang and Song Huang and Mingyou Hu},
year = {2027},
journal = {Bioorganic \& Medicinal Chemistry Letters},
doi = {10.1016/j.bmcl.2026.130779},
url = {https://doi.org/10.1016/j.bmcl.2026.130779}
}RIS
TY - JOUR TI - Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells AU - Ying Sun AU - Hongzhu Chu AU - Yonggang Wei AU - Xinying Qian AU - Fei Ye AU - Hongchuan Zhao AU - Xinying Zhu AU - Jing Zhang AU - Song Huang AU - Mingyou Hu PY - 2027 JO - Bioorganic & Medicinal Chemistry Letters DO - 10.1016/j.bmcl.2026.130779 UR - https://doi.org/10.1016/j.bmcl.2026.130779 ER -
APA
Sun, Y., Chu, H., Wei, Y., Qian, X., Ye, F., Zhao, H., Zhu, X., Zhang, J., Huang, S., & Hu, M. (2027). Discovery of potent, selective, and orally bioavailable monocyclic pyridine-based PKMYT1 inhibitors that synergize with CHK1 inhibition in replication-stressed cancer cells. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2026.130779
Source records
- crossref · retrieved 2026-09-25T07:26:56.513Z